$0.83
0.86% today
NYSE, Feb 28, 04:53 pm CET
ISIN
US81727U1051
Symbol
SENS

Senseonics Stock price

$0.83
-0.23 22.05% 1M
+0.42 104.53% 6M
+0.30 57.87% YTD
+0.16 23.33% 1Y
-0.97 54.09% 3Y
-0.56 40.55% 5Y
-2.42 74.58% 10Y
NYSE, Closing price Thu, Feb 27 2025
-0.05 5.97%
ISIN
US81727U1051
Symbol
SENS
Sector

Key metrics

Market capitalization $491.92m
Enterprise Value $514.92m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 23.18
P/S ratio (TTM) P/S ratio 22.15
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 11.41%
Revenue (TTM) Revenue $22.21m
EBIT (operating result TTM) EBIT $-77.58m
Free Cash Flow (TTM) Free Cash Flow $-63.42m
Cash position $74.80m
EPS (TTM) EPS $-0.13
P/E forward negative
P/S forward 22.23
EV/Sales forward 23.26
Short interest 7.85%
Show more

Is Senseonics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Senseonics Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Senseonics forecast:

2x Buy
40%
1x Hold
20%
2x Sell
40%

Analyst Opinions

5 Analysts have issued a Senseonics forecast:

Buy
40%
Hold
20%
Sell
40%

Financial data from Senseonics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
22 22
11% 11%
100%
- Direct Costs 25 25
42% 42%
110%
-2.33 -2.33
189% 189%
-10%
- Selling and Administrative Expenses 31 31
6% 6%
141%
- Research and Development Expense 43 43
14% 14%
191%
-76 -76
0% 0%
-343%
- Depreciation and Amortization 1.35 1.35
53% 53%
6%
EBIT (Operating Income) EBIT -78 -78
0% 0%
-349%
Net Profit -80 -80
154% 154%
-362%

In millions USD.

Don't miss a Thing! We will send you all news about Senseonics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Senseonics Stock News

Neutral
GlobeNewsWire
2 days ago
Senseonics and Ascensia integrate software between SweetSpot and Eversense 365, the world's first and only One Year CGM system
Neutral
GlobeNewsWire
15 days ago
GERMANTOWN, Md., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming TD Cowen 45th Annual Health Care Conference, being held in Boston, MA.
Neutral
GlobeNewsWire
22 days ago
GERMANTOWN, Md., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced it has filed for CE Mark registration for the Eversense® 365 CGM system.
More Senseonics News

Company Profile

Senseonics Holdings, Inc. engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a glucose monitoring device which includes sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Head office United States
CEO Timothy Goodnow
Employees 132
Founded 2014
Website www.senseonics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today